BREAKING
Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 4 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 5 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 8 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 9 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 11 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 13 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 15 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 16 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 17 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 17 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 4 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 5 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 8 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 9 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 11 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 13 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 15 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 16 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 17 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 17 hours ago
ADVERTISEMENT

Thermo Fisher Scientific (TMO) Earnings: 3Q20 Key Numbers

Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2020 earnings results today. Revenue increased 36% year-over-year to $8.52 billion. GAAP earnings jumped 157% to $1.93 billion, or $4.84 per share, compared to $760 million, or $1.88 per share, last year. Adjusted EPS increased 91% to $5.63. Prior Performance

$TMO October 21, 2020 1 min read

Thermo Fisher Scientific Inc. (NYSE: TMO) reported third quarter 2020 earnings results today.

Revenue increased 36% year-over-year to $8.52 billion.

GAAP earnings jumped 157% to $1.93 billion, or $4.84 per share, compared to $760 million, or $1.88 per share, last year. Adjusted EPS increased 91% to $5.63.

Prior Performance

Thermo Fisher Scientific Reports Second Quarter 2020 Results
ADVERTISEMENT